Start Date
August 31, 2003
Study Completion Date
January 31, 2006
ILX651
US Oncology / Albany Regional Cancer Center, Albany
US Oncology / Cancer Centers of the Carolinas, Greenville
US Oncology / Cancer Centers of Florida, Orlando
US Oncology / Dayton Oncology and Hematology, Kettering
Center for Cancer Care Research, St Louis
US Oncology / Kansas City Oncology and Hematology, Kansas City
US Oncology / Kansas City Oncology, Overland Park
US Oncology / Mary Crowley Medical Research, Dallas
US Oncology/ Tyler Cancer Center, Tyler
US Oncology /Texas Oncology, Fort Worth
St. Luke's Episcopal Hospital, Houston
Univ of Colorado Cancer Center/ Anschutz Cancer, Aurora
Arizona Cancer Center at Scottsdale, Scottsdale
Univ of Arizona Cancer Center, Tucson
USC / Norris Cancer Center, Los Angeles
Cancer Institute Medical Group, Santa Monica
Seattle Cancer Care Alliance, Seattle
US Oncology / Cancer Care Northwest, Spokane
Beth Israel Medical Center, Boston
Genzyme, a Sanofi Company
INDUSTRY